glp-1 lawsuit news today Ozempic & Gastroparesis Ozempic Lawsuit [July 2026 Update]

2.9% reported using them for weight loss (i.e., an estimated 1.6 million people), while 1.7% reported using them exclusively for weight loss (equivalent to 910,000 people) i.e., they did not use them for an additional reason such as to lower heart disease risk or regulate blood sugar levels for type 2 diabetes

However, to our knowledge, this population has not been studied at a larger scale, said presenting author Sarina Ailawadi, DO, from the Department of Medicine at Case Western Reserve University in Cleveland, Ohio, in the press release

Crucially, pair-feeding and semaglutide produced virtually identical effects on muscle, showing that muscle loss was driven by reduced calorie intake and not by anything specific to GLP-1 signaling

Commercial plans vary by employer and state, with some offering robust coverage and others denying Mounjaro entirely for weight loss purposes

While some compounding pharmacies may still carry them, most patients will have to rely on autopen devices, which provide higher doses than typically used in ME/CFS, or vials

Extensive research has been conducted on GIP's impact on inflammatory processes